Schrdinger, Inc.
SDGR
Schrdinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials scienceā¦ read more
Healthcare
Health Information Services
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$17.66
Price+2.68%
$0.46
1Y
Price
Market Cap
$1.301b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-57.4%
EBITDA Margin-60.4%
Net Profit Margin-114.8%
Free Cash Flow MarginRevenue
$256.951m
+23.8%
1y CAGR+13.1%
3y CAGR+17.6%
5y CAGREarnings
-$175.992m
+6.0%
1y CAGR-142.1%
3y CAGR-118.7%
5y CAGREPS
-$2.41
+6.2%
1y CAGR-148.0%
3y CAGR-122.7%
5y CAGRBook Value
$321.352m
$653.660m
Assets$332.308m
Liabilities$111.434m
DebtDebt to Assets
17.1%
-0.8x
Debt to EBITDAFree Cash Flow
-$3.395m
+97.9%
1y CAGR+23.6%
3y CAGR+1.7%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company